MindWalk Holdings Corp. (HYFT) vs iBio, Inc. (IBIO)

MindWalk Holdings Corp. and iBio, Inc. are both Biotechnology companies. MindWalk Holdings Corp. and iBio, Inc. are of similar size ($47.1M and $44.4M). MindWalk Holdings Corp. grew revenue faster over the last twelve months: −27.0% against −66.6%. iBio, Inc. has the higher net margin (0.00% vs −105.1%) and the higher return on invested capital (0.00% vs −464.6%). Across the 18 metrics below, iBio, Inc. leads on 12 and MindWalk Holdings Corp. on 6.

Valuation

Metric HYFT IBIO Biotechnology median
P/E n/m n/m 10.60
P/S 4.19 115.62 9.40
P/B 9.93 0.91 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 0.25 0.66
EV/Sales 4.10 (12.78) 9.02
Earnings yield (24.76%) (45.33%) (32.88%)
Free cash flow yield (18.31%) (31.04%) (23.13%)

Profitability

Metric HYFT IBIO Biotechnology median
Gross margin 60.81% 100.00% 68.51%
Operating margin (103.99%) 0.00% 0.00%
Net margin (105.06%) 0.00% 0.00%
Free cash flow margin (76.79%) 0.00% 0.00%
Return on equity (122.85%) (65.70%) (51.96%)
Return on assets (58.55%) (54.04%) (46.06%)
Return on invested capital (464.59%) 0.00% 0.00%

Growth

Metric HYFT IBIO Biotechnology median
Revenue growth (TTM) (26.99%) (66.55%) 6.76%
EPS growth (last fiscal year) 66.15% 81.71% 29.88%
Revenue growth, 5-year CAGR (3.83%) (42.83%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric HYFT IBIO Biotechnology median
Debt to equity 0.43 0.00 0.00
Current ratio 1.84 7.85 4.97
Net debt to EBITDA 0.62 2.57 1.01

Dividend

Metric HYFT IBIO Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric HYFT IBIO Biotechnology median
Market cap 47.12m 44.43m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack